OpenEvidence and AAO-HNSF Deploy AI to Streamline Clinical Guideline Updates
Event summary
- OpenEvidence and AAO-HNSF have partnered to use AI for continuous updates of clinical practice guidelines.
- The methodology systematically evaluates guideline recommendations against current medical literature.
- AAO-HNSF is the first medical society to pilot this approach for several of its guidelines.
- OpenEvidence's technology aims to reduce the manual effort required for guideline updates.
- Kristine Schulz, DrPH, MPH, Chief Research Officer of AAO-HNSF, highlights the need for timely, evidence-based guidance.
The big picture
Clinical practice guidelines are critical for standardizing patient care, but maintaining them is resource-intensive. This partnership marks a shift towards AI-augmented processes, potentially setting a new industry standard for keeping medical guidance current. The collaboration between OpenEvidence and AAO-HNSF could accelerate the evolution of clinical knowledge, addressing long-standing challenges in guideline timeliness and accuracy.
What we're watching
- Adoption Pace
- How quickly other medical societies will adopt this AI-driven approach for guideline updates.
- Efficacy Validation
- Whether the AI methodology can consistently identify and integrate relevant new evidence without compromising clinical judgment.
- Regulatory Alignment
- The extent to which regulatory bodies will recognize and endorse AI-assisted guideline updates.
Related topics